Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Nuclear localization of HIV type 1 Vif isolated from a long-term asymptomatic individual and potential role in virus attenuation.

Farrow MA, Somasundaran M, Zhang C, Gabuzda D, Sullivan JL, Greenough TC.

AIDS Res Hum Retroviruses. 2005 Jun;21(6):565-74. Erratum in: AIDS Res Hum Retroviruses. 2005 Aug;21(8):742.

PMID:
15989462
2.

Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.

Ribeiro AC, Maia e Silva A, Santa-Marta M, Pombo A, Moniz-Pereira J, Goncalves J, Barahona I.

J Virol. 2005 Jan;79(2):823-33.

3.

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.

Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. Epub 2004 Mar 30.

5.

Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS.

Sakurai A, Jere A, Yoshida A, Yamada T, Iwamoto A, Adachi A, Fujita M.

Microbes Infect. 2004 Jul;6(9):799-805.

PMID:
15374001
6.
7.

Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.

Han X, Liang W, Hua D, Zhou X, Du J, Evans SL, Gao Q, Wang H, Viqueira R, Wei W, Zhang W, Yu XF.

J Virol. 2014 Mar;88(6):3320-8. doi: 10.1128/JVI.03833-13. Epub 2014 Jan 3.

8.

Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.

Feng F, Davis A, Lake JA, Carr J, Xia W, Burrell C, Li P.

J Virol. 2004 Oct;78(19):10574-81.

9.
10.

A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.

Peng J, Ao Z, Matthews C, Wang X, Ramdahin S, Chen X, Li J, Chen L, He J, Ball B, Fowke K, Plummer F, Embree J, Yao X.

J Mol Biol. 2013 Aug 23;425(16):2840-52. doi: 10.1016/j.jmb.2013.05.015. Epub 2013 May 23.

PMID:
23707381
11.

The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.

Hassaïne G, Courcoul M, Bessou G, Barthalay Y, Picard C, Olive D, Collette Y, Vigne R, Decroly E.

J Biol Chem. 2001 May 18;276(20):16885-93. Epub 2001 Feb 27.

12.

Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.

Fujita M, Sakurai A, Doi N, Miyaura M, Yoshida A, Sakai K, Adachi A.

Microbes Infect. 2001 Nov;3(13):1093-9.

PMID:
11709289
14.
15.

RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.

Bernacchi S, Henriet S, Dumas P, Paillart JC, Marquet R.

J Biol Chem. 2007 Sep 7;282(36):26361-8. Epub 2007 Jul 2.

16.

Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.

Khan MA, Akari H, Kao S, Aberham C, Davis D, Buckler-White A, Strebel K.

J Virol. 2002 Sep;76(18):9112-23.

17.
18.

Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein.

Friedler A, Zakai N, Karni O, Friedler D, Gilon C, Loyter A.

J Mol Biol. 1999 Jun 11;289(3):431-7.

PMID:
10356319
19.

Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals.

Hassaïne G, Agostini I, Candotti D, Bessou G, Caballero M, Agut H, Autran B, Barthalay Y, Vigne R.

Virology. 2000 Oct 10;276(1):169-80.

20.

T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner.

Vallanti G, Lupo R, Federico M, Mavilio F, Bovolenta C.

Mol Ther. 2005 Oct;12(4):697-706.

PMID:
16039909
Items per page

Supplemental Content

Write to the Help Desk